Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Arthritis Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Arthritis Other
    Gene Expression Findings May Help Classify, Predict, and Treat Juvenile Arthritis - (DGNews)
    Golimumab Shows Sustained Efficacy in Ankylosing Spondylitis Over 104 Weeks: Presented at EULAR - (DGDispatch)
    Golimubab Shows Long-Term Efficacy in Treatment of Psoriatic Arthritis: Presented at EULAR - (DGDispatch)
    FDA Approves Golimumab for Treating 3 Types of Immune-Related Arthritis - (DGNews)
    Golimumab Approved for Psoriatic Arthritis, Ankylosing Spondylitis, and RA in Canada - (DGNews)

    News archive

     Recent webcasts/CME - Arthritis Other
    Moderate-to-Severe Psoriasis and Psoriatic Arthritis: Reducing the Clinical and Economic Burden Through Effective Treatment Protocols

    Webcasts/CME archive

     Recent cases - Arthritis Other
      Concurrent Reactive Arthritis and Myelitis - A Case Report
      Infectious Arthritis of the Knee Caused by Mycobacterium Terrae: A Case Report
      An Elderly Woman with an Age-Old Disease
      Chronic Slowly Progressive Monoarthritis Tuberculosis of the Hip Without Systemic Symptoms Mimicking Osteoarthritis: A Case Report
      Arthritis of the Sternoclavicular Joint Masquerading as Rupture of the Cervical Oesophagus: A Case Report

      Cases archive
        




      my personal edition > arthritis other > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Arthritis Prevalence in Patients Over 65 Will Double Over a 25 Year Period

      Morbidity and Mortality Weekly Report

      06/06/2003
      By Deanna M. Green


      Cases of arthritis and chronic joint symptoms in people over 65 are projected to double between 2005 and 2030, according to a recent American study.

      Incidence of arthritis and other rheumatic conditions, such as chronic joint symptoms (CJS), is known to increase with age. This puts the elderly at the greatest risk of developing these nonfatal yet disabling conditions.

      Furthermore, given that US adults are living longer due to better management of other chronic diseases and lower mortality from infectious diseases, the population of people over 65 continues to grow; thereby increasing the number of people at risk of developing arthritis.

      Jennifer M. Hootman, PhD, and colleagues at the Centres for Disease Control and Prevention, Atlanta, Georgia, United States, estimated the projected future burden of arthritis or CJS in this group.

      Estimates were made using patient-reported diagnoses of arthritis or CJS obtained from the 2001 Behavioural Risk Factor Surveillance System, a random telephone survey of US adults over the age of 18, and US Census projections of the national population for 2005 to 2030.

      Census reports estimated that the number of US citizens over the age of 65 will increase from 12.9% of the population in 2005 to 20.0% in 2030. Moreover, if current incidence rates within this population are applied, the number of people with arthritis or CJS will double from 21.4 million in 2005 to 41.1 million in 2030.

      In addition, specific predictions using individual state prevalence rates and population projections indicated that Hawaii will have the lowest incidence (34.8%) and Alabama will have the highest incidence (70.3%) of arthritis within this population. This analysis predicts that in 11 states and Puerto Rico about 60% of people over 65 with have arthritis or CJS in 2025.

      Based on these projections, Dr. Hootman recommends that "proven public health interventions should be applied and new interventions developed to improve function, decrease pain, and delay disability among persons with arthritis, particularly those at highest risk for functional impairment and disability."
      Morbidity and Mortality Weekly Report 2003;52:21:489-491.

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send